Immune biological agent for inducing specific immunity against severe acute respiratory syndrome virus SARS-CoV-2

The invention relates to biotechnology, immunology and virology, in particular to an immune biological agent for preventing diseases caused by severe acute respiratory syndrome virus SARS-CoV-2. Furthermore, a method of inducing a specific immunity against the SARS-CoV-2 virus is disclosed, which co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ESMAGAMBETOV IGOR BORISOVICH, SEBLYAKOV DMITRY VLADIMIROVICH, ZUBKOVA OLGA VLADIMIROVNA, TUKHVATULLIN, ALEKSANDR IVANOVICH, SHCHERBININ DMITRY NIKOLAEVICH, SEMIHIN ALEKSANDR SERGEEVICH, TUHVATURINA NATALIA M, NARODITSKY BORIS SERGEEVICH, LOGUNOV, DIMITRI, Y, GINZBURG, ALAN, L, ZARURAYEVA, ANNA, S, POPOVA OLGA, TOKARSKAYA, ELENA, A, OZAROVSKAIA TATYANA ALEXANDROVNA, GRUSOVA DARYA MIKHAILOVNA, DORZHIKOVA IRINA VLADIMIROVNA, BERTIKOV ALEXEI GRIGORIEVICH, BORISEVICH SERGEY VLADIMIROVICH
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to biotechnology, immunology and virology, in particular to an immune biological agent for preventing diseases caused by severe acute respiratory syndrome virus SARS-CoV-2. Furthermore, a method of inducing a specific immunity against the SARS-CoV-2 virus is disclosed, which comprises administering to a mammal one or more immune biological agents for preventing a disease caused by the Severe Acute Respiratory Syndrome virus SARS-CoV-2. The present invention promotes the effective induction of an immune response to the SARS-CoV-2 virus. 本发明涉及生物技术、免疫学和病毒学，尤其涉及一种用于预防由严重急性呼吸综合征病毒SARS-CoV-2引起的疾病的免疫生物剂。此外，还公开了一种诱导对所述SARS-CoV-2病毒的特异性免疫的方法，其包括向哺乳动物施用一种或多种用于预防由严重急性呼吸综合征病毒SARS-CoV-2引起的疾病的免疫生物剂。本发明促进了对所述SARS-CoV-2病毒的免疫反应的有效诱导。